1. Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017 Subject(s): Antibodies, Monoclonal -- therapeutic useDermatitis, Atopic -- drug therapyInterleukin-4 Receptor alpha Subunit -- antagonists & inhibitorsPhosphodiesterase 4 Inhibitors -- therapeutic useAntibodies, Monoclonal -- adverse effectsCost-Benefit AnalysisCyclosporine -- therapeutic usePhosphodiesterase 4 Inhibitors -- adverse effectsPhototherapyRandomized Controlled Trials as TopicTreatment OutcomeHumansUnited States
